ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Lost Money on Replimune Group, Inc. ( REPL ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
Replimune ( REPL ) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- A new securities class action has been initiated against Replimune Group, Inc. REPL and certain executives, arising out of the company's recent stock price collapse. The lawsuit, officially known as Jboor v. Replimune Group, Inc., et al., No. ...
Class Action Filed Against Replimune Group, Inc. ( REPL ) Seeking Recovery for Investors - Contact The Gross Law Firm - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. REPL. Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
REPL Investors Have the Opportunity to Lead the Replimune Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options
Replimune ( REPL ) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- A new securities class action has been initiated against Replimune Group, Inc. REPL and certain executives, arising out of the company's recent stock price collapse. The lawsuit, officially known as Jboor v. Replimune Group, Inc., et al., No. ...
Shareholders of Replimune Group, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
Replimune ( REPL ) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 ( D. Mass. ) , has been filed and seeks to represent investors who purchased or otherwise acquired Replimune ( NASDAQ:REPL ) securities between ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 16, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket - Applied Mat ( NASDAQ:AMAT ) , 180 Life Sciences ( NASDAQ:ATNF )
Shares of KULR Technology Group, Inc. KULR rose sharply in pre-market trading after the company reported better-than-expected quarterly financial results. KULR Technology reported second-quarter revenue of $3.97 million, beating estimates of $3.5 million, according to Benzinga Pro.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. REPL. Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Shareholders who lost money on Replimune Group, Inc. ( NASDAQ: REPL ) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased the securities of Replimune Group, Inc. REPL ( "Replimune" or the "Company" )
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Replimune Group ( REPL ) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Replimune Group ( NASDAQ:REPL )
ATLANTA, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- A shareholder class action lawsuit has been filed against Replimune Group, Inc. ( "Replimune" or the "Company" ) REPL. The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse ...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Replimune Group, Inc. ( REPL ) Shareholders - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 10, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Shareholders of Replimune Group, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
ROSEN, THE FIRST FILING FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Replimune ( REPL ) Q1 Loss Widens 61%
Replimune Group ( NASDAQ:REPL ) , a biotechnology company specializing in oncolytic immunotherapies for cancer, reported its earnings for the first quarter of fiscal 2026 on August 7, 2025. The most notable headline was the U.S.
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm - Alto Neuroscience ( NYSE:ANRO ) , Neogen ( NASDAQ:NEOG )
NEW YORK, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation NEOG, Alto Neuroscience, Inc. ANRO, RxSight, Inc.
Replimune Group, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
REPL DEADLINE: Replimune Group Investors Should Contact Block & Leviton By September 22nd To Join Securities Fraud Lawsuit - Replimune Group ( NASDAQ:REPL )
BOSTON, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Replimune Group, Inc. REPL and certain of its executives.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Shareholders that lost money on Replimune Group, Inc. ( REPL ) Urged to Join Class Action - Contact The Gross Law Firm to Learn More - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. REPL. Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results - CommScope Holding Co ( NASDAQ:COMM ) , BT Brands ( NASDAQ:BTBD )
U.S. stocks traded higher midway through trading, with the S&P 500 gaining more than 1% on Monday. The Dow traded up 1.27% to 44,141.11 while the NASDAQ climbed 1.82% to 21,026.44. The S&P 500 also rose, gaining, 1.37% to 6,323.33. Communication services shares jumped by 2.3% on Monday.
Why Is Replimune Stock Trading Lower On Monday? - Replimune Group ( NASDAQ:REPL )
Replimune shares plunged nearly 43% in the past month following FDA's rejection of its cancer drug. Daily volume surged to 15.9 million vs. 7.9 million average as a lawsuit alleged misleading statements over the IGNYTE trial. The market's back, and these 3 income stocks are thriving. See them here→
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Replimune Group ( REPL ) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Replimune Group ( NASDAQ:REPL )
ATLANTA, Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- A shareholder class action lawsuit has been filed against Replimune Group, Inc. ( "Replimune" or the "Company" ) REPL. The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse ...
Kosmos Energy Posts Downbeat Q2 Results, Joins HilleVax And Other Big Stocks Moving Lower In Monday's Pre-Market Session - HilleVax ( NASDAQ:HLVX ) , Kosmos Energy ( NYSE:KOS )
U.S. stock futures were higher this morning, with the Dow futures gaining more than 200 points on Monday. Shares of Kosmos Energy Ltd. KOS fell sharply in pre-market trading after the company reported worse-than-expected second-quarter results.
REPLIMUNE GROUP, INC. ( NASDAQ: REPL ) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Replimune Group, Inc. Investors of Upcoming Deadline - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Replimune Group, Inc. ( "Replimune" or the "Company" ) REPL investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the ...
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Adial Pharmaceuticals ( NASDAQ:ADIL ) , ATA Creativity Global ( NASDAQ:AACG )
Shares of CommScope Holding Company, Inc. COMM rose sharply in pre-market trading. The Wall Street Journal reported Sunday that Amphenol is nearing a deal for CommScope's Broadband arm. CommScope Holding shares jumped 40.1% to $10.91 in the pre-market trading session.
Bragar Eagel & Squire, P.C. Is Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm - Alto Neuroscience ( NYSE:ANRO ) , Neogen ( NASDAQ:NEOG )
NEW YORK, Aug. 02, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation NEOG, Alto Neuroscience, Inc. ANRO, RxSight, Inc.
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Replimune Group, Inc. REPL between November 22, 2024 and July 21, 2025, both dates inclusive ( the ...
Replimune ( REPL ) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman
SAN FRANCISCO, Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 ( D. Mass. ) , has been filed and seeks to represent investors who purchased or otherwise acquired Replimune ( NADAQ: REPL ) securities between ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options
Important Notice to Long-Term Shareholders of Centene Corporation ( NYSE: CNC ) ; Flywire Corporation ( NASDAQ: FLYW ) ; Replimune Group, Inc. ( NASDAQ: REPL ) ; and Sable Offshore Corporation ( NYSE: SOC ) : Grabar Law Office is Investigating Claims on Your Behalf - Flywire ( NASDAQ:FLYW ) , Centene ( NYSE:CNC )
PHILADELPHIA, Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Centene Corporation CNC. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Alignment Healthcare ( NASDAQ:ALHC ) , Align Technology ( NASDAQ:ALGN )
Shares of Meta Platforms, Inc. META rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above estimates.
US Stocks Edge Higher; Kraft Heinz Earnings Top Views - BioNexus Gene Lab ( NASDAQ:BGLC ) , Kraft Heinz ( NASDAQ:KHC )
U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 0.1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.06% to 44,660.57 while the NASDAQ rose 0.19% to 21,138.92. The S&P 500 also rose, gaining, 0.10% to 6,377.27.
Important Notice to Short and Long-Term Shareholders of DoubleVerify Holdings, Inc. ( NYSE: DV ) ; Flywire Corporation ( NASDAQ: FLYW ) ; Replimune Group, Inc. ( NASDAQ: REPL ) ; and Sable Offshore Corporation ( NYSE: SOC ) : Grabar Law Office is Investigating Claims on Your Behalf - DoubleVerify Holdings ( NYSE:DV ) , Flywire ( NASDAQ:FLYW )
PHILADELPHIA, July 30, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating whether certain officers and directors of DoubleVerify Holdings, Inc. DV breached their fiduciary duties owed to the company. If you have held DoubleVerify Holdings, Inc.
REPL INVESTORS: Replimune Group, Inc. ( NASDAQ:REPL ) Investors may have been Affected by Fraud - Contact BFA Law by September 22 about Potentially Recovering Losses - Replimune Group ( NASDAQ:REPL )
NEW YORK, July 30, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Replimune Group, Inc. REPL and certain of the Company's senior executives for potential violations of the federal securities laws.
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs ( NASDAQ:AEHL ) , AtriCure ( NASDAQ:ATRC )
Shares of LendingClub Corporation LC rose sharply in pre-market trading after the company reported better-than-expected second-quarter sales results. LendingClub reported a strong second-quarter performance, with a 156% increase in net income.
Shareholders who lost money on Replimune Group, Inc. ( NASDAQ: REPL ) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - Replimune Group ( NASDAQ:REPL )
NEW YORK, July 29, 2025 ( GLOBE NEWSWIRE ) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased the securities of Replimune Group, Inc. REPL ( "Replimune" or the "Company" )
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm - Alto Neuroscience ( NYSE:ANRO ) , Neogen ( NASDAQ:NEOG )
NEW YORK, July 28, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation NEOG, Alto Neuroscience, Inc. ANRO, RxSight, Inc.
Replimune ( REPL ) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, July 28, 2025 ( GLOBE NEWSWIRE ) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 ( D. Mass. ) , has been filed and seeks to represent investors who purchased or otherwise acquired Replimune ( NASDAQ:REPL ) securities between ...
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, July 28, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Replimune Group, Inc. REPL between November 22, 2024 and July 21, 2025, both dates inclusive ( the ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, July 28, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. ( "Replimune" or the "Company" ) REPL. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ( or 888.4-POMLAW ) ...
REPL Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Replimune Group, Inc. - Replimune Group ( NASDAQ:REPL )
SAN DIEGO, July 28, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. REPL securities between November 22, 2024 and July 21, 2025.
Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. ( NYSE: ANRO ) ; Luminar Technologies, Inc. ( NASDAQ: LAZR ) ; Replimune Group, Inc. ( NASDAQ: REPL ) ; and RxSight, Inc. ( NASDAQ: RXST ) : Grabar Law Office is Investigating Claims on Your Behalf - Alto Neuroscience ( NYSE:ANRO ) , Luminar Technologies ( NASDAQ:LAZR )
PHILADELPHIA, July 27, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Alto Neuroscience, Inc. ANRO. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Class Action Filed Against Replimune - September 22, 2025 Deadline to Join - Contact Faruqi & Faruqi
Class Action Filed Against Replimune - September 22, 2025 Deadline to Join - Contact ...
Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare - And Trade Deal Optimism Boosts Markets Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare - And Trade Deal Optimism Boosts Markets - Cigna Group ( NYSE:CI ) , C3.ai ( NYSE:AI )
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. Wall Street rallied as a wave of new trade deals - including agreements with Japan, Indonesia, and the Philippines - fueled optimism, pushing the S&P 500 and Nasdaq ...
REPL CLASS ACTION ALERT: FDA Response Letter Leads to Replimune Group, Inc. Class Action - Investors are Notified to Contact BFA Law by September 22 Deadline - Replimune Group ( NASDAQ:REPL )
NEW YORK, July 26, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Replimune Group, Inc. REPL and certain of the Company's senior executives for potential violations of the federal securities laws.
